Movement Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Movement Disorders stocks.

Movement Disorders Stocks Recent News

Date Stock Title
Nov 21 OMER Omeros Corporation Provides Update on Progress Toward BLA Resubmission
Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Nov 20 MDT Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth
Nov 20 MDT Medtronic reports rise in Q2 FY 2025 net income to $1.27bn
Nov 20 MDT Healing People and Planet: New Impact Report Outlines How Medtronic Is Shaping the Future of Health
Nov 20 MDT Medtronic receives FDA clearance for new InPen app
Nov 20 MDT Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
Nov 20 MDT Jim Cramer on Medtronic plc (MDT): ‘It Has Been A Winner’
Nov 20 MDT Medtronic Second Quarter 2025 Earnings: Beats Expectations
Nov 20 MDT Medtronic PLC (MDT) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth Amid ...
Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
Nov 19 MDT Medtronic (MDT) Q2 2025 Earnings Call Transcript
Nov 19 MDT Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Nov 19 MDT Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook
Nov 19 MDT Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know
Nov 19 MDT Medtronic plc (MDT) Q2 2025 Earnings Call Transcript
Nov 19 MDT Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise
Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
Movement Disorders

Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, unrelated to weakness or spasticity. Movement disorders are synonymous with basal ganglia or extrapyramidal diseases. Movement disorders are conventionally divided into two major categories- hyperkinetic and hypokinetic.
Hyperkinetic movement disorders refer to dyskinesia, or excessive, often repetitive, involuntary movements that intrude upon the normal flow of motor activity.
Hypokinetic movement disorders refer to akinesia (lack of movement), hypokinesia (reduced amplitude of movements), bradykinesia (slow movement) and rigidity. In primary movement disorders, the abnormal movement is the primary manifestation of the disorder. In secondary movement disorders, the abnormal movement is a manifestation of another systemic or neurological disorder.

Browse All Tags